Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
The Cochrane Database of Systematic Reviews
|
May 14, 2025
Total neoadjuvant therapy for locally advanced rectal cancer
Sophie Mueller, Yung-Shuo Kao, Carolin Kastner, et al.
Nature Communications
|
October 5, 2022
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis
Carmen Aguilar, Mindaugas Pauzuolis, Malvika Pompaiah, et al.
Scientific Reports
|
February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
Jochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
BJS Open
|
March 7, 2023
Applicability of the surgical risk calculator by the American College of Surgeons in the setting of German patients undergoing complete pancreatectomy: multicentre study using data from the StuDoQ|Pancreas registry
Philipp Höhn, Fabian Runde, Andreas Minh Luu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 23, 2025
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)
Franziska Köhler, Dirk Arnold, Daniela Aust, et al.
The Lancet. Gastroenterology & Hepatology
|
December 18, 2020
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Volker Kunzmann, Jens T Siveke, Hana Algül, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials
Emmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Cihan Gani, Emmanouil Fokas, Bülent Polat, et al.
JAMA Surgery
|
June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Julia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
The EMBO Journal
|
February 27, 2025
Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer
Ivana Paskov Škapik, Chiara Giacomelli, Sarah Hahn, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
The Cochrane Database of Systematic Reviews
|
May 14, 2025
Total neoadjuvant therapy for locally advanced rectal cancer
Sophie Mueller, Yung-Shuo Kao, Carolin Kastner, et al.
Nature Communications
|
October 5, 2022
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis
Carmen Aguilar, Mindaugas Pauzuolis, Malvika Pompaiah, et al.
Scientific Reports
|
February 13, 2025
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
Jochen Gaedcke, Malte Sahrhage, Marcel Ebeling, et al.
BJS Open
|
March 7, 2023
Applicability of the surgical risk calculator by the American College of Surgeons in the setting of German patients undergoing complete pancreatectomy: multicentre study using data from the StuDoQ|Pancreas registry
Philipp Höhn, Fabian Runde, Andreas Minh Luu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 23, 2025
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)
Franziska Köhler, Dirk Arnold, Daniela Aust, et al.
The Lancet. Gastroenterology & Hepatology
|
December 18, 2020
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Volker Kunzmann, Jens T Siveke, Hana Algül, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials
Emmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial
Cihan Gani, Emmanouil Fokas, Bülent Polat, et al.
JAMA Surgery
|
June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Julia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
The EMBO Journal
|
February 27, 2025
Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer
Ivana Paskov Škapik, Chiara Giacomelli, Sarah Hahn, et al.
Page
of 23